UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
176 civic groups furious over government-doctors deal
by Kim Eun-young
2020-09-04 18:14
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
by Lee Han-soo
2020-09-04 18:04
UBcare wins patent for tech to monitor suspected infectious diseases
by Shim Hyun-tai
2020-09-04 18:04
SCM Lifescience punished for delaying adverse reaction report
by Kim Chan-hyuk
2020-09-04 14:54
Doctors to end strike as government puts healthcare policy on hold
by Kwak Sung-sun
2020-09-04 14:53
라인
Despite slowing down virus cases, tight restrictions continue in Seoul
by Lee Han-soo
2020-09-04 14:16
Iraq approves Hutox as 1st BTX product
by Lee Han-soo
2020-09-04 14:16
Pharmaceuticals, CROs have hard time doing clinical trials amid prolonged pandemic
by Lee Han-soo
2020-09-03 19:24
8 in 10 clinical professors willing to act collectively
by Song Soo-youn
2020-09-03 16:29
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
by Kim Yun-mi
2020-09-03 14:50
라인
‘Cyramza helped improve gastric cancer treatment in Korea’
by Kim Yun-mi
2020-09-03 14:49
Chong Kun Dang to conduct P2 trials of Covid-19 therapy in Russia
by Shim Hyun-tai
2020-09-03 12:36
Daewoong to expand indication of Nabota in US
by Lee Han-soo
2020-09-03 12:13
New virus cases fall below 200 but critical patients surge
by Lee Han-soo
2020-09-03 11:27
Recovered Covid-19 patients suffer from aftereffects – for long
by Shim Hyun-tai
2020-09-02 20:12
라인
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
by Kim Yun-mi
2020-09-02 16:33
Nation struggles to secure beds, workforce for severe Covid-19 patients
by Shim Hyun-tai
2020-09-02 16:15
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
by Lee Han-soo
2020-09-02 15:20
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
by Shim Hyun-tai
2020-09-02 14:08
[Column] Correct diagnosis leads to proper treatment
by Shin Eui-cheol
2020-09-02 13:10
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top